Eli Lillys 4 Billion Vaccine Push Signals Strategic Expansion in Infectious Disease Nifty 50 Faces Critical Test at 24000 as 52Day EMA Adds Technical Significance Drone Manufacturers Quantum and Destinus Reportedly Engage Banks for Potential 2027 IPOs US Prioritizes Integration of American AI Technologies in Asia Following HighLevel Diplomatic Engagement Meta Tests AI Subscription Services Starting at 799 Per Month Canadas Big Banks Face Investor Scrutiny on Q2 Earnings Amid Slowing Economy Welltower Inc WELL Q1 2026 Earnings Outsized EPS Beat Driven by Strong Operating Fundamentals Spectrum Brands Holdings Inc SPB Q1 2026 Earnings EPS Surges Past Estimates as Stock Reacts Positively CYN Q1 2026 Earnings EPS Surprise of 264 Highlights Cost Discipline Amid Revenue Void HWM Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Aerospace Demand Cheche Group Q4 2024 Earnings Narrowed Loss Beats Estimates Despite Stock Decline ROKU Q1 2026 Earnings EPS Surges Past Estimates with 71 Beat ITHAX Acquisition Corp III ITHAU Units Hold Steady at 1004 Amid Consolidation Sila Realty Trust SILA Holds Steady Near 3020 Testing Key Support and Resistance Levels Vera Therapeutics VERA Edges Higher Testing Resistance Amid Steady Volume Montrose Environmental Group MEG Surges Over 5 as Environmental Services Sector Gains Momentum Madrigal Pharmaceuticals MDGL Edges Higher as Bullish Momentum Builds New Repayment Assistance Plan RAP to Become Primary IncomeBased Option for Federal Student Loan Borrowers Starting July 2026 ALT Q1 2026 Earnings Narrowed Loss and EPS Beat Signal Progress in Metabolic Pipeline Kartoon Studios TOON Slides 286 as Stock Tests Key Support Near 065 OZK Q1 2026 Earnings Marginal EPS Miss Amid Solid Underlying Performance TGEN Q1 2026 Earnings BetterThanExpected Losses Drive Positive Stock Reaction WDC Q1 2026 Earnings EPS Surges Past Estimates Stock Jumps 834 YI Q3 2024 Earnings EPS Loss of 0145 Highlights Ongoing Operational Headwinds Upstream Bio UPB Q1 2026 Earnings NarrowerThanExpected Loss Amid No Revenue Stock Edges Lower IMVT Q1 2026 Earnings EPS Misses Estimates as Clinical Investment Intensifies Frontier Group Holdings ULCC Q1 2026 Earnings Narrowing Losses Fuel Optimism as EPS Surprises to the Upside